Subscribe

Subscribe

Latest Content

Solar

Storage

Wind

Event Spotlight

BLOGS

DISTRIBUTECH+ RECAP: Energy Storage Utility Case Studies

Webcast

OPINION

RESOURCES

CLARION ENERGY MEDIA

POWER & ENERGY EVENT SERIES

Privacy Policy

Copyright © 2019 - 2021

Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech Bull 3X Direxion (NY: LABU )

126.84 -0.08 (-0.06%)
Streaming Delayed Price Updated: 3:14 PM EDT, Sep 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,006,492
Open 125.50
Bid (Size) 126.52 (1)
Ask (Size) 126.61 (3)
Prev. Close 126.92
Today's Range 124.61 - 131.75
52wk Range 48.40 - 176.99
Shares Outstanding 73,744
Dividend Yield 0.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Can These 5 Assets Skyrocket Your Portfolio?
Are Verizon, Amazon, Cisco, Amgen, and the S&P Biotech Bull 3X Shares ETF poised to make your portfolio skyrocket? In this video, I take a closer look. 
Via Talk Markets
Topics ETFs Stocks
Exposures US Equities
EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks
Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment. 
Via Benzinga

Performance

YTD
+0.87%
+0.87%
1 Month
-10.07%
-10.07%
3 Month
+10.58%
+10.58%
6 Month
-0.82%
-0.82%
1 Year
+84.36%
+84.36%

More News

Read More
Tech Powers S&P 500, Nasdaq, Leveraged ETFs Win
Via Talk Markets
Topics ETFs Stocks
Exposures US Equities
The 3 Best Leveraged ETFs for April 2024
Via InvestorPlace
Topics ETFs
Sector Rotation
Via Talk Markets
5 Best-Performing Leveraged ETFs Of February
Via Talk Markets
Topics ETFs Stocks
Exposures US Equities
Stocks To Watch This Week - Sunday, Feb. 11
Via Talk Markets
Topics ETFs
Want Diversified Upside in Biotechnology? Check out LABU
Via MarketBeat
Topics ETFs Stocks
Exposures US Equities
The Week Ahead Commentary - Saturday, Feb. 4
Via Talk Markets
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
Via Talk Markets
3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty
Via InvestorPlace
The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)…
Via Talk Markets
3 Biotech Stocks to Buy That Are Under Severe Pressure
Via InvestorPlace
5 Best Leveraged ETFs of Last Week
Via Talk Markets
5 Best-Performing Leveraged ETFs of August
Via Talk Markets
The Week In Charts: Figure This Out And You’ll Own The World
Via Talk Markets
The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs
Via Talk Markets
The Week In Charts: Trading Stuff Part 2-IPOs, ETFs, And, The Secret To Trading
Via Talk Markets
These Were The Stocks David Green Discussed On His Show This Morning
Via Benzinga
The Week In Charts-Volatility: Rabbit Hole Or Holy Grail?
Via Talk Markets
A Biotech ETF For Aggressive, Risk-Tolerant Investors
Via Talk Markets
Topics Stocks
Exposures US Equities
A Biotech ETF For Aggressive, Risk-Tolerant Investors
Via Benzinga
Exposures Product Safety
CrowdStrike Stock Earnings Trade
Via Talk Markets
This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.